High IgE in a 24-Year-Old Male - Clinical Approach

Normal Reference Range

Causes of Elevated IgE

1. Atopic/Allergic Conditions (most common)

• Allergic rhinitis - one of the most prevalent causes in young adults
• Atopic dermatitis (eczema)
• Allergic asthma
• Food allergy - peanuts, tree nuts, shellfish, etc.
• Insect venom hypersensitivity
• Occupational allergy (e.g., latex)

2. Parasitic Infections (classic cause of markedly elevated IgE)

3. Allergic Bronchopulmonary Aspergillosis (ABPA)

• Requires IgE >1000 IU/mL as a major criterion
• Seen in patients with asthma or cystic fibrosis
• Also requires positive Aspergillus skin test or specific IgE to A. fumigatus
• This is one of the most diagnostically useful indications for total IgE measurement

4. Primary Immunodeficiency Syndromes with High IgE

• IgE levels from 2,000 to 50,000 kU/L (extremely high)
• Recurrent staphylococcal infections (skin abscesses, pneumonia with pneumatoceles)
• Eczema and eosinophilia
• Coarse facial features
• Despite markedly elevated IgE and strong immediate skin-test reactivity, asthma is NOT common

5. Other/Miscellaneous

• Certain malignancies (some lymphomas, especially Hodgkin's)
• IgE myeloma (very rare)
• Graft-versus-host disease
• Heavy smoking

Approach to Investigation in This Patient

1. Complete blood count with differential - look for eosinophilia (common in parasitic infection and hyper-IgE syndrome)
2. Quantify total IgE level - the degree of elevation guides the differential:
   • Mildly elevated (41-200 kU/L): atopy most likely
   • Moderately elevated (200-1000 kU/L): atopy, early parasitic disease
   • Markedly elevated (>1000 kU/L): parasitic infection, ABPA, or hyper-IgE syndrome most likely
3. Allergen-specific IgE panel - guided by history (inhalants, foods, occupation)
4. Stool O&P (ova and parasites) x3 + serology for relevant parasites based on travel/exposure history
5. Chest X-ray / pulmonary function - if respiratory symptoms
6. Aspergillus-specific IgE and precipitins - if asthma or pulmonary infiltrates present

• STAT3 gene mutation testing
• Immunology referral

Key Clinical Pearl

• Total IgE in allergic disease typically ranges from mildly to moderately elevated
• Total IgE in ABPA must exceed 1000 IU/mL to meet diagnostic criteria
• Total IgE in hyper-IgE syndrome is usually 2000-50,000 kU/L - extreme elevation
• Total IgE in parasitic disease regularly exceeds 1000 kU/L

Pruritus (Itch) - Comprehensive Overview

Definition & Epidemiology

IFSI Classification of Chronic Pruritus

• Group I - Pruritus on inflamed skin (e.g., atopic dermatitis, urticaria, psoriasis)
• Group II - Pruritus on normal-appearing skin (systemic or neurologic cause more likely)
• Group III - Pruritus with chronic scratch lesions (prurigo nodularis)

In This Patient (High IgE + Pruritus)

1. Atopic Dermatitis (AD) - Most Likely

• Pruritus is the defining and most distressing symptom of AD - it is one of the major diagnostic criteria (Hanifin-Rajka criteria: pruritus is obligatory)
• Other major features: facial/extensor rash in infants, flexural lichenification, personal/family history of atopic triad (AD, asthma, allergic rhinitis)
• In AD, histamine is NOT the primary mediator of itch - this explains why antihistamines have relatively poor efficacy in AD compared to urticaria
• The itch-scratch cycle worsens the skin barrier and promotes S. aureus colonization (>70% of AD patients)
• Nocturnal pruritus is characteristic and leads to sleep disruption, anxiety, and depression (43-57% of adult AD patients screen positive for these comorbidities)

2. Urticaria

• Pruritic wheals are IgE/mast cell-driven
• Histamine IS the dominant mediator here - antihistamines work well
• H1 antihistamines are first-line (loratadine, fexofenadine, cetirizine)

3. Parasitic Infection (especially with IgE >1000 kU/L)

• Pruritus can be prominent (e.g., hookworm causing cutaneous larva migrans, schistosomiasis - "swimmer's itch")

Pathophysiology of IgE-Mediated Itch

1. Allergen cross-links IgE on mast cells/basophils
2. Degranulation releases histamine, tryptase, prostaglandins, leukotrienes
3. Histamine binds H1 receptors on unmyelinated C-fibers in skin
4. Signal travels via dorsal root ganglia → spinothalamic tract → somatosensory cortex
5. In AD specifically, additional mediators dominate: IL-31 (the "itch cytokine"), substance P, TSLP, IL-4/IL-13 - which is why anti-IL-31 (nemolizumab) and dupilumab (anti-IL-4Rα) are more effective than antihistamines in AD

Management of Pruritus - Step-by-Step

General Measures (all causes)

• Emollients daily to prevent xerosis and restore skin barrier
• Avoid identified allergens and irritants
• Cool environment (heat worsens itch)
• Topical antipruritic compounds: urea, menthol, polidocanol

Targeted Therapy by Etiology

Antihistamines in Detail

• Sedating (1st gen): Diphenhydramine, hydroxyzine - useful at bedtime for nocturnal itch; anticholinergic side effects (urinary retention, dry mouth, constipation)
• Non-sedating (2nd gen): Loratadine, fexofenadine, cetirizine - preferred daytime use, can dose up to 4x daily for chronic urticaria
• Doxepin: Dual H1/H2 blocker + TCA; 10-75 mg at night; also available as 5% topical cream (short-term)
• Key point: Antihistamines provide poor itch control in AD because histamine is not the primary pruritogen there

Phototherapy

• NB-UVB effective for renal, cholestatic, polycythemia vera-associated, and chronic urticaria-associated pruritus
• PUVA effective for aquagenic pruritus and photodermatoses

Biologics & Emerging Therapies

• Omalizumab (anti-IgE): Approved for chronic spontaneous urticaria refractory to antihistamines - particularly relevant for a patient with high IgE
• Dupilumab (anti-IL-4Rα): First-line biologic for moderate-to-severe AD
• Nemolizumab (anti-IL-31Rα): Targets the primary itch cytokine in AD
• Remibrutinib (BTK inhibitor): Phase III data shows promise in chronic spontaneous urticaria resistant to H1 antagonists

Bottom Line for This Patient

• The most likely diagnosis is atopic dermatitis or allergic urticaria
• If IgE is markedly elevated (>1000), consider parasitic infection or ABPA alongside
• Start workup: CBC with differential (eosinophil count), allergen-specific IgE panel, stool O&P if travel history suggests parasites
• Empirical management: emollients + non-sedating H1 antihistamine while workup proceeds
• If AD confirmed: step up to topical corticosteroids or calcineurin inhibitors; biologics (dupilumab) for moderate-severe disease
• If chronic urticaria: antihistamines → omalizumab if refractory (directly targets IgE axis)

Pruritus on Normal Skin (IFSI Group II) + High IgE - No Primary Rash

Revised Differential Diagnosis (High Priority)

1. Parasitic Infection (Top Priority with High IgE)

• Scabies - classic distribution spares the face and scalp in adults (face involvement mainly in infants). Burrows are found in interdigital webs, wrists, elbows, axillae, genitals, belt line. The itch is worse at night and mediated by immunologic sensitization to the mite. However, IgE is only modestly elevated in typical scabies.
• Tissue-invasive helminths (hookworm, ascariasis, strongyloidiasis, toxocariasis, filariasis, schistosomiasis) - these markedly elevate IgE (>1000 kU/L) and cause generalized pruritus without a primary rash. Travel history is critical.
• Onchocerciasis ("river blindness") - causes persistent severe generalized pruritus often without a visible rash initially; endemic to sub-Saharan Africa/Latin America

2. Hematologic Malignancy

A population-based study found patients with chronic pruritus without skin findings had a 2-fold increased risk of hematologic malignancy and 3.7-fold increased risk of bile duct malignancy - making workup mandatory in this patient.

3. Early/Occult Bullous Dermatoses

• Bullous pemphigoid (pre-bullous phase) - presents as intense generalized pruritus for weeks/months before blisters appear; IgE can be elevated; more common in elderly but reported in young adults
• Dermatitis herpetiformis - pruritic, associated with celiac disease; anti-tTG IgA antibodies diagnostic; lesions may be excoriated and not recognized as primary

4. Systemic/Metabolic Causes

5. Drug-Induced Pruritus

• Opioids (histamine release from mast cells)
• ACE inhibitors, statins, diuretics, NSAIDs
• Always take a full medication history

Stepwise Investigation (from Dermatology textbook - Table 6.3)

Basic Initial Evaluation (Order First)

• CBC with differential and platelets - look for eosinophilia (parasites, hypereosinophilic syndrome), polycythemia, lymphocytosis
• ESR, CRP
• Creatinine, BUN - renal disease
• LFTs: transaminases, alkaline phosphatase, bilirubin - hepatic/cholestatic disease
• LDH - lymphoma marker
• TSH - thyroid disease
• Fasting glucose - diabetes
• Serum ferritin, iron, TIBC - iron deficiency

Additional Evaluation (Based on Initial Results)

• Skin biopsy with direct immunofluorescence - even normal-appearing skin can show bullous pemphigoid or dermatitis herpetiformis
• Serum total and allergen-specific IgE - already elevated; now test specific allergens
• Serum protein electrophoresis / immunofixation - paraprotein
• Viral hepatitis panel (HBV, HCV) + HIV testing
• Anti-BP180 and anti-BP230 antibodies - bullous pemphigoid
• Anti-tissue transglutaminase IgA - dermatitis herpetiformis/celiac
• Serum tryptase - mastocytosis
• Stool for ova and parasites (x3 samples)
• Parathyroid function (Ca, PO4, PTH)

Imaging

• Chest X-ray or CT - lymphadenopathy, mediastinal mass (Hodgkin)
• Abdominal/pelvic ultrasound or CT - hepatosplenomegaly, lymphadenopathy
• Lymph node ultrasonography

Physical Examination Focus

• Palpate all peripheral lymph node groups (cervical, supraclavicular, axillary, inguinal) - essential in pruritus without skin disease
• Look for hepatosplenomegaly
• Skin: assess for dermographism, excoriations, subtle burrows

Most Likely Diagnosis in This Patient